BigBear.ai Holdings, Inc. (BBAI)

BigBear.ai's stock closed at $2.32 after falling 5.31% in the latest session, leaving it near the bottom of its 52-week range at $2.07 to $7.40. The shares are 68.65% below their 52-week high, 33.39% below the 200-day moving average and down 59.37% over the past year. The pressure comes as the company keeps missing earnings estimates while revenue continues to grow, so the debate centers on whether top-line gains can turn into profit. Revenue grew 31.50% in the latest quarter year on year, ahead of the sector median of 24.2%. Yet the October 27, 2026 report showed adjusted EPS of -$0.19 against an estimate of -$0.05, the fifth-quarter record in which the company beat estimates only once. CleaRank rates the stock Sell with a score of 25 out of 100, more cautious than Wall Street's Hold consensus.

The clearest positive in the figures is the top line. Revenue grew 31.50% in the latest quarter year on year, faster than the sector median of 24.2%, and analysts expect revenue for this fiscal year to rise 22.0% to $155.7M. That growth is the factor that most lifts the company's CleaRank score. The problem is that it has not reached the bottom line. The net profit margin is -126.84% and the operating margin is -53.00%, and return on equity of -27.90% trails the sector median of 13.4%. Analysts expect an adjusted loss of -$0.41 per share for this fiscal year, and the company's reported earnings per share over the last twelve months are -$0.32.

The October 27, 2026 report was another miss. Adjusted EPS came in at -$0.19 against an estimate of -$0.05, a shortfall of 280.00%. The stock rose 4.68% in the first session after that report, but the gain did not hold. Cantor Fitzgerald kept its Neutral rating on October 28, 2026, and again on July 31, 2026.

At 7.86 times sales, the stock trades 3.4% above the sector median price-to-sales ratio of 7.6, which is a modest premium for a company with negative earnings. The trend is the heaviest drag on the score. The price is 9.79% below its 50-day SMA and 33.39% below its 200-day SMA, and the 50-day SMA is 26.16% below the 200-day SMA. The 14-day RSI of 45.7 sits in the neutral zone, while the MACD line is negative. Insiders sold $1.4M of stock across 11 sales over the last 18 months and made no open-market purchases. Those sales are often planned in advance or made to cover taxes on vesting shares, so they carry less weight than purchases would.

The base case for the coming months is that BBAI trades in a wide, downward-leaning range while it works to close its profitability gap. For the trend to improve, the stock would need to reclaim the 20-day EMA at $2.40 and then the 50-day SMA at $2.57, which would show selling pressure easing. Sustained revenue growth above the sector median, combined with narrower EPS misses, would strengthen that case. The two covering analysts both hold Neutral ratings with targets from $3.00 to $3.50 and a median of $3.25, which sits 40.1% above the price. A break below the 52-week low of $2.07 would weaken the base case and point toward a retest of lower prices, since the stock has already fallen 12.08% above the past year. The stock's beta of 3.38 means moves in either direction can be large, and the typical daily move is 5.28%.

Support sits at the 52-week low of $2.07, the nearest level below the price. A close that breaks this floor would mark a new low for the past year and would be the main risk to the current setup. Resistance comes first at the 20-day EMA of $2.40, the level a recovery would meet first, followed by the 50-day SMA at $2.57. The 200-day SMA at $3.48 is the next major hurdle above that, and the 52-week high of $7.40 is the most distant level on the chart.